Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid againstBranhamella catarrhalis (original) (raw)
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
References
- Amsterdam, D., Jones, R. N. In vitro technical comment_Branhamella catarrhalis_ assessing beta-lactamase production. Antimicrobial Newsletter 1985, 2: 79–90.
Google Scholar - Calder, M. A., Croughan, M. J., McLeod, D. T., Ahmad, F. The incidence and antibiotic susceptibility of_Branhamella catarrhalis_ in respiratory infections in 1986. Drugs, 1987, 31, Supplement 3: 12–16.
Google Scholar - Aldridge, K. E., Shiro, D. D., Sanders, C. V. Comparative in vitro activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 170–172.
PubMed Google Scholar - Kayser, F. H. Comparative antibacterial activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 309–312.
PubMed Google Scholar - Leitner, Felix, Pursiano, T. A., Buck, R. E., Tsai, Y. H., Chisholm, D. R., Misiek, M., Desiderio, J. V., Kessler, R. E. BMY-28100, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1987, 31: 238–243.
PubMed Google Scholar